DrugPatentWatch Database Preview
Cipla Company Profile
What is the competitive landscape for CIPLA, and what generic and branded alternatives to CIPLA drugs are available?
CIPLA has eighty-two approved drugs.
There are thirty-two tentative approvals on CIPLA drugs.
Summary for Cipla
| US Patents: | 0 |
| Tradenames: | 73 |
| Ingredients: | 73 |
| NDAs: | 82 |
| Patent Litigation for Cipla: | See patent lawsuits for Cipla |
| PTAB Cases with Cipla as petitioner: | See PTAB cases with Cipla as petitioner |
Drugs and US Patents for Cipla
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipla | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 210362-002 | Jun 19, 2018 | AO | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Cipla | MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 207463-001 | Oct 28, 2016 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Cipla | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 077073-003 | Sep 26, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Cipla | VALGANCICLOVIR HYDROCHLORIDE | valganciclovir hydrochloride | TABLET;ORAL | 209672-001 | Nov 9, 2018 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Cipla Ltd | ZIDOVUDINE | zidovudine | CAPSULE;ORAL | 078349-001 | May 23, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
